Jakafi 10 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FKAP9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,240
Award facts
- Contract value 100% obligated
- $33,240.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a $33,240.32 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). The delivery order, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, contains no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. Performance will take place at the contractor's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion acquisition vehicle awarded on November 13, 2025. The PPV-G GEN V program, structured as a $30.3 billion acquisition strategy, establishes multiple regional prime vendor contractors to supply a comprehensive range of pharmaceutical products—including branded and generic prescription medications, biologics, and medical consumables—to support Department of Defense military healthcare operations worldwide. DMS Pharmaceutical Group holds the sole award under this IDC with a base period through December 31, 2036, positioning the company as a critical pharmaceutical supplier for the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FKAP9?
SPE2DR26FKAP9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FKAP9 worth?
The government has obligated $33,240 on SPE2DR26FKAP9.
Is contract SPE2DR26FKAP9 an order under another contract?
Yes. SPE2DR26FKAP9 is a delivery order under SPE2DR25D9365, an indefinite delivery contract.
Was contract SPE2DR26FKAP9 competed?
The extent of competition for SPE2DR26FKAP9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award